Vericel (VCEL) Change in Account Payables (2019 - 2026)
Vericel's (VCEL) quarterly Change in Account Payables came in at $2.6 million in Q1 2026, up 570.05% year-on-year from $386535.8 in Q1 2025, and up 263.25% quarter-over-quarter from $713000.0 in Q4 2025.
Vericel (VCEL) Change in Account Payables (2019 - 2026) Analysis & Trends
Vericel has disclosed Change in Account Payables across 8 years of filings, most recently posting $2.6 million for Q1 2026.
- Change in Account Payables for Q1 2026 came in at $2.6 million, up 570.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.1 million (up 51.17% YoY), and the FY2025 annual result was $3.0 million, up 1136.24% from the prior year.
- Change in Account Payables came in at $2.6 million for Q1 2026 at Vericel, up from $713000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $4.7 million in Q2 2024 to a low of -$4.9 million in Q1 2024.
- The 5-year median for Change in Account Payables is $713000.0 (2025), against an average of $574294.1.
- Across the five-year window, Change in Account Payables sank 1682.12% in 2024 and jumped 570.05% in 2026, its largest moves.
- Vericel's Change in Account Payables stood at $1.5 million in 2022, then jumped by 82.43% to $2.7 million in 2023, then plunged by 49.72% to $1.4 million in 2024, then slumped by 47.26% to $713000.0 in 2025, then surged by 263.25% to $2.6 million in 2026.
- The last three Change in Account Payables figures came in at $2.6 million (Q1 2026), $713000.0 (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.59 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 713,000.00 |
| Dec 31, 2025 | 713,000.00 |
| Sep 30, 2025 | 2.80 Mn |
| Sep 30, 2025 | 2.80 Mn |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | -551,000.00 |
| Mar 31, 2025 | -551,000.00 |
| Dec 31, 2024 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Jun 30, 2024 | 4.67 Mn |
| Jun 30, 2024 | 4.67 Mn |
| Mar 31, 2024 | -4.88 Mn |
| Mar 31, 2024 | -4.88 Mn |
| Dec 31, 2023 | 2.69 Mn |
| Dec 31, 2023 | 2.69 Mn |